Trials / Completed
CompletedNCT06046170
Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)
Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA): A Randomized Control
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Baylor College of Medicine · Academic / Other
- Sex
- All
- Age
- 7 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Anxiety is very common in autistic youth. Recently, an intervention has been created by the investigators to target these symptoms in autistic youth in a community setting. The purpose of this study is to determine the feasibility of implementing this treatment in community care centers.
Detailed description
As many as 50% of autistic youth have at least 1 anxiety disorder. Cognitive-behavioral therapy (CBT) for autistic youth is effective at treating anxiety, but access is limited. The investigators have tailored the treatment to make it more accessible to families in the participants' home communities. The purpose of this project is to investigate how feasible it is to implement Community-Based Anxiety Programs Tailored for Autism (CAPTA) in community settings.
Conditions
- Anxiety
- Autism Spectrum Disorder
- Separation Anxiety
- Generalized Anxiety Disorder
- Social Anxiety Disorder of Childhood
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Cognitive Behavioral Therapy | Participants will receive cognitive behavioral therapy with elements of exposure in order to target anxious behaviors. |
| OTHER | Treatment as Usual | Participants will receive treatment as usual at a community mental health center, including receiving skills training. |
Timeline
- Start date
- 2024-01-15
- Primary completion
- 2025-12-30
- Completion
- 2026-02-28
- First posted
- 2023-09-21
- Last updated
- 2026-03-05
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06046170. Inclusion in this directory is not an endorsement.